drugset / Trial / NCT00971295

Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers

NCT00971295

Phase 1 Completed 20 enrolled Bial - Portela C S.A.
RandomizedCrossoverOpen-labelTreatment

Summary

The primary objective was to investigate whether multiple-dose administration of eslicarbazepine acetate affects the pharmacokinetics of metformin.

Timeline

Start
2007-10
Primary completion
2007-12
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Eslicarbazepine acetate Unknown 1200 mg Oral
Subject Metformin Small molecule 850 mg

Indications